Dave Schemelia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZyVersa Therapeutics Highlights Publication Indicating That

NLRP3-Mediated Inflammation in Obese Children Leads to Insulin Resistance and Risk of Complications (e.g., Type 2 Diabetes, Hypertension, Heart Disease)..

Stephenc gloverDave schemeliaCasey mcdonaldZyversa therapeutics incSecurities exchangeVersa therapeuticsTranslational medicineZyversa therapeuticsCholesterol efflux mediatorSecurities exchange actPrivate securities litigation reform actNasdaq zvsaZyversa therapeuticsChildhood obesityInsulin resistanceNflammasome asc inhibitor

ZyVersa Therapeutics Announces Peer-Reviewed Article

Activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer’s Disease (AD)..

United statesCasey mcdonaldReginat vontellStephenc gloverRobertw keaneDave schemeliaUniversity of miami miller school medicineTranslational research clinical interventionsBrain endowment bankZyversa therapeutics incResearch assistant professorSecurities exchangeTiberend strategic advisors incVersa therapeuticsTranslational researchAssociate director

ZyVersa Therapeutics Highlights Peer-Reviewed Article

NLRP3 Inflammasome Activation Is Linked to Brain Metastasis in Patients with Triple-Negative Breast Cancer. .

Casey mcdonaldDave schemeliaStephenc gloverZyversa therapeutics incActa neuropathologica communicationsSecurities exchangeVersa therapeuticsZyversa therapeuticsCholesterol efflux mediatorSecurities exchange actPrivate securities litigation reform actNasdaq zvsaZyversa therapeuticsTriple negative breast cancerBrain metastasisInflammasome activation

Cyrano Therapeutics Secures $9 0 Million Series B Financing to Advance Clinical Development of CYR-064 for Treatment of Post-Viral Smell Loss

Phase 2 FLAVOR clinical trial currently enrolling 150 patients to assess the safety and effectiveness of CYR-064 in treating patients with chronic smell loss following recovery from a viral infection

United statesDelray beachDave schemeliaRick geoffrionEric reissPrnewswire cyrano therapeutics incFlorida opportunity fundCyrano therapeutics incDeepwork capitalLumira venturesCyrano therapeuticsVenture partnerWork capital

ZyVersa Therapeutics CEO, Stephen C Glover, Featured on Benzinga All Access

ZyVersa Therapeutics CEO, Stephen C Glover, Featured on Benzinga All Access
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Casey mcdonaldDave schemeliaStephenc gloverSecurities exchangeZyversa therapeutics incExchange commissionVersa therapeuticsChief executive officerBenzinga allCholesterol effluxInvestigational new drugZyversa therapeuticsSecurities exchange actPrivate securities litigation reform actAnnual reportQuarterly reports